Journal Article10.2174/1573405620666230508104538
An efficient ensemble based machine learning approach for predicting Chronic Kidney Disease.
6
TL;DR: In this paper , the authors proposed an ensemble learning approach in which the top three best performing classifiers in terms of cross-validation results are stacked in an ensemble model after balancing the dataset using SMOTE.
read more
Abstract: BACKGROUND
Chronic kidney disease (CKD) is a long-term risk to one's health that can result in kidney failure. CKD is one of today's most serious diseases, and early detection can aid in proper treatment. Machine learning techniques have proven to be reliable in the early medical diagnosis.
OBJECTIVE
The paper aims to perform CKD prediction using machine learning classification approaches. The dataset used for the present study for detecting CKD was obtained from the machine learning repository at the University of California, Irvine (UCI).
METHOD
In this study, twelve machine learning-based classification algorithms with full features were used. Since the CKD dataset had a class imbalance issue, the Synthetic Minority Over-Sampling technique (SMOTE) was used to alleviate the problem of class imbalance and review the performance based on machine learning classification models using the K fold cross-validation technique. The proposed work compares the results of twelve classifiers with and without the SMOTE technique, and then the top three classifiers with the highest accuracy, Support Vector Machine, Random Forest, and Adaptive Boosting classification algorithms were selected to use the ensemble technique to improve performance.
RESULTS
The accuracy achieved using a stacking classifier as an ensemble technique with cross-validation is 99.5%.
CONCLUSION
The study provides an ensemble learning approach in which the top three best-performing classifiers in terms of cross-validation results are stacked in an ensemble model after balancing the dataset using SMOTE. This proposed technique could be applied to other diseases in the future, making disease detection less intrusive and cost-effective.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Edge AI for Early Detection of Chronic Diseases and the Spread of Infectious Diseases: Opportunities, Challenges, and Future Directions
TL;DR: The role of Edge AI in early health prediction is reviewed and its potential to improve public health is highlighted and future research directions to address concerns and the integration with existing healthcare systems are emphasized.
26
Improving Enhanced Clinical Decision Making : Chronic Kidney Disease Detection
Bharathi Mohan G. India,Sreenath Vadlamudi,Chaitanya Reddy Guggella,Haneef Pinjari,Pranav Reddy Sanikommu +4 more
- 29 Dec 2023
TL;DR: This research introduces a creative method that has implications, in the medical field, that can be improve patient outcomes for slow down disease advancement allow for intervention and tailor treatment plans, to patients.
Applying stacking ensemble method to predict chronic kidney disease progression in Chinese population based on laboratory information system: a retrospective study
Jialin Du,Jie Gao,Jie Guan,Bo Jin,Nan Duan,Lu Pang,Haiming Huang,Wei Ma,Chen‐Wei Huang,Haixia Li +9 more
TL;DR: This retrospective study develops and validates a machine-learned model using laboratory variables and electronic health records to predict chronic kidney disease progression in the Chinese population, aiming to improve clinical decision-making and patient outcomes.
Fuzzy Logic based Expert System for Early Predicting of Chronic Kidney Disease
Abdeljalil El-Ibrahimi,Sara Laghmati,Khadija Hicham,Soufiane Hamida,Bouchaib Cherradi,Omar Bouattane +5 more
- 16 May 2024
TL;DR: Fuzzy logic-based expert system for early predicting of chronic kidney disease achieves high accuracy of 100%.
Comparative Analysis of Random, Grid, and Optimization-Based Hyperparameter Tuning for Feature Selection Methods on a Preprocessed Chronic Kidney Disease Dataset
Subashini. N.J,Venkatesh K. +1 more
- 25 Jul 2025
TL;DR: This study compares Random Search, Grid Search, and Bayesian Optimization for hyperparameter tuning of feature selection methods on a preprocessed Chronic Kidney Disease dataset, finding Grid Search outperforms others with an average accuracy improvement of 2.3% and SFS achieving the best accuracy of 0.9991.
References
SMOTE: synthetic minority over-sampling technique
TL;DR: In this article, a method of over-sampling the minority class involves creating synthetic minority class examples, which is evaluated using the area under the Receiver Operating Characteristic curve (AUC) and the ROC convex hull strategy.
XGBoost Model for Chronic Kidney Disease Diagnosis
Adeola Ogunleye,Qing-Guo Wang +1 more
TL;DR: The set-theory based rule is presented which combines a few feature selection methods with their collective strengths and the reduced model using about a half of the original full features performs better than the models based on individual feature selection method and achieves accuracy, sensitivity, and specificity.
625
Risk Factors for Chronic Kidney Disease: A Prospective Study of 23,534 Men and Women in Washington County, Maryland
Melanie K. Haroun,Bernard G. Jaar,Sandra C. Hoffman,George W. Comstock,Michael J. Klag,Josef Coresh +5 more
TL;DR: CKD risk shows strong graded relationships to the sixth report of the Joint National Committee on Prevention, Detection Evaluation and Treatment of High BP criteria for BP, to diabetes, and to current cigarette smoking that are at least as strong in women as in men.
594
Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration.
Andrew S. Levey,Daniel C. Cattran,Aaron L. Friedman,W. Greg Miller,John R. Sedor,Katherine R. Tuttle,Bertram L. Kasiske,Thomas H. Hostetter +7 more
TL;DR: There appears to be sufficient evidence to recommend changes in proteinuria as a surrogate for kidney disease progression in only selected circumstances, and collaboration among many groups, including academia, industry, the FDA, and the National Institutes of Health are recommended to share data from past and future studies.
298